Clinical Trials Directory

Trials / Terminated

TerminatedNCT03022838

The Effects of Caffeine Withdrawal on Migraine

The Effects of Caffeine Withdrawal on Migraine - a Randomized, Double-blind, Crossover Study

Status
Terminated
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Nordlandssykehuset HF · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Sporadic and chronic dietary consumption of caffeine has substantial biological effects on the nervous system. The effects on migraine are at large not known. In this study we want to assess the effects of caffeine withdrawal on migraine.

Detailed description

The actions of caffeine as an antagonist of adenosine receptors have been extensively studied, and there is no doubt that both daily and sporadic dietary consumption of caffeine has substantial biological effects on the nervous system. The current opinion is that caffeine both can cure and trigger headaches. Caffeine is a component of many combination drugs marketed for the relief of headaches, but on the other hand it is strongly incriminated as a risk factor for developing chronic headache. Withdrawal may cause symptom constellations similar to the migraine syndrome. Further, caffeine consumption may affect sleep and alertness, possibly influencing the risk of migraine attacks. .

Conditions

Interventions

TypeNameDescription
DRUGCaffeineFrom the point of enrollment, patients will substitute their daily dietary caffeine with either placebo- or capsulated caffeine tablets (Recip®, 100mg).

Timeline

Start date
2017-02-28
Primary completion
2019-07-22
Completion
2019-07-22
First posted
2017-01-18
Last updated
2019-07-23

Locations

3 sites across 1 country: Norway

Source: ClinicalTrials.gov record NCT03022838. Inclusion in this directory is not an endorsement.